Celleration Inc., an Eden Prairie, Minn.-based maker of a non-contact ultrasound device for medical applications like wound-care, has expanded its Series D round from $25 million to $30 million, according to a regulatory filing. Shareholders include Venture Investors LLC, Upper Lake Growth Capital, Baird Venture Partners, Aavin Equity Advisors, Triathlon Medical Ventures and New Science Ventures.
It has now raised over $60 million since 2002. JMP Securities served as placement agent on the Series D round. www.celleration.com